Associate Professor
Fred Hutchinson Cancer Research Center / Seattle Care Cancer Alliance / University of Washington School of Medicine, Seattle, WA
Disclosure: Allogene (Individual(s) Involved: Self): Ad hoc advisory board (last 12 months), Other Financial or Material Support; ArsenalBio (Individual(s) Involved: Self): Advisor or Review Panel member, Other Financial or Material Support, Stock/options; AstraZeneca (Individual(s) Involved: Self): Ad hoc advisory board (last 12 months), Grant/Research Support, Other Financial or Material Support; Caribou Biosciences (Individual(s) Involved: Self): Advisor or Review Panel member, Other Financial or Material Support, Stock/options; Century Therapeutics (Individual(s) Involved: Self): Advisor or Review Panel member; Eureka Therapeutics (Individual(s) Involved: Self): Advisor or Review Panel member, Other Financial or Material Support, Stock/options; Juno Therapeutics (Individual(s) Involved: Self): Grant/Research Support, Other Financial or Material Support, Patent: Licensed to Juno Therapeutics; Myeloid Therapeutics (Individual(s) Involved: Self): Advisor or Review Panel member, Other Financial or Material Support, Stock/options; Nektar Therapeutics (Individual(s) Involved: Self): Ad hoc advisory board (last 12 months), Grant/Research Support, Other Financial or Material Support; PACT Pharma (Individual(s) Involved: Self): Ad hoc advisory board (last 12 months), Other Financial or Material Support; Precision Biosciences (Individual(s) Involved: Self): Advisor or Review Panel member, Other Financial or Material Support, Stock/options; TCR2 Therapeutics (Individual(s) Involved: Self): Grant/Research Support; T-CURX (Individual(s) Involved: Self): Advisor or Review Panel member
